ESR1 and breast cancer: Using this cellular model, we were able to demonstrate that low doses of NO-donor induce cell proliferation, high metabolic activity, downregulation of ER and collective invasion in BC spheroids that are sensitive to estrogen-induced apoptosis, thus contributing to more aggressive phenotypes.